Format

Send to

Choose Destination
Oncotarget. 2016 Jul 19;7(29):45849-45862. doi: 10.18632/oncotarget.9968.

Tumor suppressor berberine binds VASP to inhibit cell migration in basal-like breast cancer.

Author information

1
Department of Nephrology, Renmin Hospital of Wuhan University, Wuhan 430060, P. R. China.
2
Department of Pathophysiology, School of Medicine, Wuhan University, Wuhan 430071, P. R. China.
3
Department of Pathology, Shanghai First People's Hospital, Shanghai 200080, P. R. China.
4
Department of Pharmacy, Wuhan General Hospital of Guangzhou Command, Wuhan 430070, P. R. China.
5
Department of Plant Science, College of Life Sciences, Wuhan University, Wuhan 430072, P. R. China.
6
Department of Pharmacology, College of Pharmacy, Wuhan University, Wuhan 430071, P. R. China.
7
Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan 430060, P. R. China.
8
Department of Oncology, Zhongnan Hospital of Wuhan University, Wuhan 430071, P. R. China.

Abstract

Berberine is a plant-derived compound used in traditional Chinese medicine, which has been shown to inhibit cell proliferation and migration in breast cancer. On the other hand, vasodilator-stimulated phosphoprotein (VASP) promotes actin filament elongation and cell migration. We previously showed that VASP is overexpressed in high-motility breast cancer cells. Here we investigated whether the anti-tumorigenic effects of berberine are mediated by binding VASP in basal-like breast cancer. Our results show that berberine suppresses proliferation and migration of MDA-MB-231 cells as well as tumor growth in MDA-MB-231 nude mouse xenografts. We also show that berberine binds to VASP, inducing changes in its secondary structure and inhibits actin polymerization. Our study reveals the mechanism underlying berberine's inhibition of cell proliferation and migration in basal-like breast cancer, highlighting the use of berberine as a potential adjuvant therapeutic agent.

KEYWORDS:

VASP; basal-like subtype breast cancer; berberine; polymerization

PMID:
27322681
PMCID:
PMC5216765
DOI:
10.18632/oncotarget.9968
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Impact Journals, LLC Icon for PubMed Central
Loading ...
Support Center